📊 UNH Key Takeaways
Is Unitedhealth Group Inc. (UNH) a Good Investment?
UnitedHealth demonstrates strong revenue growth of 11.8% YoY and solid free cash flow generation of $16.1B, indicating operational effectiveness in a stable healthcare sector. However, net income declined 5.9% YoY despite revenue growth, suggesting margin compression from inflationary cost pressures and claims expenses that warrant monitoring. The company maintains adequate liquidity and reasonable leverage with 4.7x interest coverage, though tight current ratio of 0.79x reflects typical healthcare industry working capital dynamics.
UnitedHealth shows strong scale, double-digit revenue growth, and solid free cash flow generation, which support the durability of its franchise. However, declining net income and EPS, thin margins, and sub-1.0 liquidity ratios suggest growth quality has weakened and near-term financial flexibility should be watched more closely.
Why Buy Unitedhealth Group Inc. Stock? UNH Key Strengths
- Strong revenue growth of 11.8% YoY demonstrating market expansion
- Robust free cash flow of $16.1B with 3.6% FCF margin providing financial flexibility
- Solid interest coverage ratio of 4.7x indicating manageable debt service capacity
- Reasonable debt-to-equity ratio of 0.72x maintaining financial stability
- Significant cash position of $24.4B supporting operations and shareholder returns
- Revenue grew 11.8% year over year to $447.57B, indicating strong demand and market position
- Free cash flow of $16.07B and operating cash flow of $19.70B provide meaningful internal funding capacity
- Balance sheet leverage appears manageable with debt-to-equity of 0.72x and positive returns on equity and assets
UNH Stock Risks: Unitedhealth Group Inc. Investment Risks
- Net income declined 5.9% YoY despite 11.8% revenue growth indicating margin compression and rising medical costs
- Operating margin of only 4.2% leaves limited buffer for adverse business conditions in regulated healthcare sector
- Current ratio of 0.79x below 1.0x threshold raises liquidity concerns, though typical for healthcare insurers
- Diluted EPS declined 14.7% YoY signaling profitability pressures exceeding revenue growth benefits
- Low net margin of 2.7% reflects competitive healthcare market with limited pricing power
- Net income fell 5.9% and diluted EPS declined 14.7%, signaling pressure on earnings quality
- Operating margin of 4.2% and net margin of 2.7% leave limited room for execution mistakes or cost inflation
- Current ratio of 0.79x and interest coverage of 4.7x indicate tighter liquidity and only moderate debt-servicing cushion
Key Metrics to Watch
- Net margin trend and ability to expand profitability without revenue acceleration
- Medical loss ratio and claims expense trends relative to premium revenue
- Operating cash flow sustainability and free cash flow conversion
- Current ratio and working capital management in light of insurance premium collection cycles
- Operating margin and net margin trend
- Net income/EPS growth versus revenue growth
Unitedhealth Group Inc. (UNH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 3.6% FCF margin may limit capital allocation flexibility. The current ratio below 1.0x warrants monitoring of short-term liquidity.
UNH Profit Margin, ROE & Profitability Analysis
UNH vs Healthcare Sector: How Unitedhealth Group Inc. Compares
How Unitedhealth Group Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Unitedhealth Group Inc. Stock Overvalued? UNH Valuation Analysis 2026
Based on fundamental analysis, Unitedhealth Group Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Unitedhealth Group Inc. Balance Sheet: UNH Debt, Cash & Liquidity
UNH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Unitedhealth Group Inc.'s revenue has grown significantly by 56% over the 5-year period, indicating strong business expansion. The most recent EPS of $23.86 reflects profitable operations.
UNH Revenue Growth, EPS Growth & YoY Performance
UNH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $100.8B | $2.3B | $2.59 |
| Q2 2025 | $98.9B | $2.8B | $3.02 |
| Q1 2025 | $99.8B | -$1.4B | $-1.53 |
| Q3 2024 | $92.4B | $5.8B | $6.24 |
| Q2 2024 | $92.9B | $2.8B | $3.02 |
| Q1 2024 | $91.9B | -$1.4B | $-1.53 |
| Q3 2023 | $80.9B | $5.3B | $5.55 |
| Q2 2023 | $80.3B | $5.1B | $5.34 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Unitedhealth Group Inc. Dividends, Buybacks & Capital Allocation
UNH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Unitedhealth Group Inc. (CIK: 0000731766)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Apr 6, 2026 | 4 | xslF345X06/wk-form4_1775509488.xml | View → |
| Apr 6, 2026 | 4 | xslF345X06/wk-form4_1775509482.xml | View → |
| Apr 6, 2026 | 4 | xslF345X06/wk-form4_1775509476.xml | View → |
| Apr 6, 2026 | 4 | xslF345X06/wk-form4_1775509470.xml | View → |
| Apr 6, 2026 | 4 | xslF345X06/wk-form4_1775509464.xml | View → |
❓ Frequently Asked Questions about UNH
What is the AI rating for UNH?
Unitedhealth Group Inc. (UNH) has a Combined AI Rating of BUY from Claude (BUY) and ChatGPT (HOLD) with 76% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are UNH's key strengths?
Claude: Strong revenue growth of 11.8% YoY demonstrating market expansion. Robust free cash flow of $16.1B with 3.6% FCF margin providing financial flexibility. ChatGPT: Revenue grew 11.8% year over year to $447.57B, indicating strong demand and market position. Free cash flow of $16.07B and operating cash flow of $19.70B provide meaningful internal funding capacity.
What are the risks of investing in UNH?
Claude: Net income declined 5.9% YoY despite 11.8% revenue growth indicating margin compression and rising medical costs. Operating margin of only 4.2% leaves limited buffer for adverse business conditions in regulated healthcare sector. ChatGPT: Net income fell 5.9% and diluted EPS declined 14.7%, signaling pressure on earnings quality. Operating margin of 4.2% and net margin of 2.7% leave limited room for execution mistakes or cost inflation.
What is UNH's revenue and growth?
Unitedhealth Group Inc. reported revenue of $447.6B.
Does UNH pay dividends?
Unitedhealth Group Inc. pays dividends, with $7,916.0M distributed to shareholders in the trailing twelve months.
Where can I find UNH SEC filings?
Official SEC filings for Unitedhealth Group Inc. (CIK: 0000731766) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is UNH's EPS?
Unitedhealth Group Inc. has a diluted EPS of $13.23.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is UNH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Unitedhealth Group Inc. has a BUY rating with 76% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is UNH stock overvalued or undervalued?
Valuation metrics for UNH: ROE of 12.0% (sector avg: 15%), net margin of 2.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy UNH stock in 2026?
Our dual AI analysis gives Unitedhealth Group Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is UNH's free cash flow?
Unitedhealth Group Inc.'s operating cash flow is $19.7B, with capital expenditures of $3.6B. FCF margin is 3.6%.
How does UNH compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 2.7% (avg: 12%), ROE 12.0% (avg: 15%), current ratio 0.79 (avg: 2).